source
- 5th Circuit reinstates in-person dispensing for mifepristone, prompting Supreme Court stay and industry concernsThe 5th Circuit Court of Appeals reversed a prior ruling and required mifepristone to be dispensed only in person. Danco, the drug's maker, asked the Supreme Court for relief and received a one-wee…
- Celcuity reports positive Phase 3 data for gedatolisib, bolstering broader approval prospectsCelcuity announced new data from an ongoing Phase 3 trial of its experimental breast cancer drug gedatolisib. The data showed that two- and three-drug combinations that included gedatolisib delaye…